Biomedical Engineering Reference
In-Depth Information
5.
Alternative calibrant materials, such as synthetic oligonucleotides ( 34 ) or plas-
mid with inserts of targeted genes ( 35 ) , have also been reported.
6.
The protocol focuses on the use of real-time quantitative PCR for fetal DNA
detection in maternal plasma. However, other assay platforms have also been
adopted for fetal DNA detection, including conventional PCR, which is less sen-
sitive ( 3 ) ; and mass spectrometry, which has both superior sensitivity and speci-
ficity ( 36 ) .
7.
Many groups perform triplicate analyses ( 30 , 37 ) , and it has been reported that
analytical results can be interpreted with greater confidence when higher number
of replicates are performed ( 38 ) .
References
1. Lo, Y. M. D., Corbetta, N., Chamberlain, P. F., et al. (1997) Presence of fetal
DNA in maternal plasma and serum. Lancet 350, 485-487.
2. Lo, Y. M. D., Tein, M. S., Lau, T. K., et al. (1998) Quantitative analysis of fetal
DNA in maternal plasma and serum: implications for noninvasive prenatal diag-
nosis. Am. J. Hum. Genet. 62, 768-775.
3. Birch, L., English, C. A., O'Donoghue, K., Barigye, O., Fisk, N. M., and Keer, J.
T. (2005) Accurate and robust quantification of circulating fetal and total DNA in
maternal plasma from 5 to 41 weeks of gestation. Clin. Chem. 51, 312-320.
4. Gonzalez-Gonzalez, C., Garcia-Hoyos, M., Trujillo-Tiebas, M. J., et al. (2005)
Application of fetal DNA detection in maternal plasma: a prenatal diagnosis unit
experience. J. Histochem. Cytochem. 53, 307-314.
5. Lo, Y. M. D., Zhang, J., Leung, T. N., Lau, T. K., Chang, A. M., and Hjelm, N. M.
(1999) Rapid clearance of fetal DNA from maternal plasma. Am. J. Hum. Genet.
64, 218-224.
6. Ariga, H., Ohto, H., Busch, M. P., et al. (2001) Kinetics of fetal cellular and cell-
free DNA in the maternal circulation during and after pregnancy: implications for
noninvasive prenatal diagnosis. Transfusion 41, 1524-1530.
7. Smid, M., Galbiati, S., Vassallo, A., et al. (2003) No evidence of fetal DNA per-
sistence in maternal plasma after pregnancy. Hum. Genet. 112, 617-618.
8. Lo, Y. M. D., Leung, T. N., Tein, M. S., et al. (1999) Quantitative abnormalities
of fetal DNA in maternal serum in preeclampsia. Clin. Chem. 45, 184-188.
9. Farina, A., Sekizawa, A., Rizzo, N., et al. (2004) Cell-free fetal DNA (SRY locus)
concentration in maternal plasma is directly correlated to the time elapsed from
the onset of preeclampsia to the collection of blood. Prenat. Diagn. 24, 293-297.
10. Lo, Y. M. D., Lau, T. K., Zhang, J., et al. (1999) Increased fetal DNA concentra-
tions in the plasma of pregnant women carrying fetuses with trisomy 21. Clin.
Chem. 45, 1747-1751.
11. Wataganara, T., LeShane, E. S., Farina, A., et al. (2003) Maternal serum cell-free
fetal DNA levels are increased in cases of trisomy 13 but not trisomy 18. Hum.
Genet. 112, 204-208.
12. Leung, T. N., Zhang, J., Lau, T. K., Hjelm, N. M., and Lo, Y. M. D. (1998) Mater-
nal plasma fetal DNA as a marker for preterm labour. Lancet 352, 1904-1905.
 
Search WWH ::




Custom Search